468 related articles for article (PubMed ID: 26314964)
1. Resistance to anticancer vaccination effect is controlled by a cancer cell-autonomous phenotype that disrupts immunogenic phagocytic removal.
Garg AD; Elsen S; Krysko DV; Vandenabeele P; de Witte P; Agostinis P
Oncotarget; 2015 Sep; 6(29):26841-60. PubMed ID: 26314964
[TBL] [Abstract][Full Text] [Related]
2. ROS-induced autophagy in cancer cells assists in evasion from determinants of immunogenic cell death.
Garg AD; Dudek AM; Ferreira GB; Verfaillie T; Vandenabeele P; Krysko DV; Mathieu C; Agostinis P
Autophagy; 2013 Sep; 9(9):1292-307. PubMed ID: 23800749
[TBL] [Abstract][Full Text] [Related]
3. Emerging Roles of Calreticulin in Cancer: Implications for Therapy.
Venkateswaran K; Verma A; Bhatt AN; Shrivastava A; Manda K; Raj HG; Prasad A; Len C; Parmar VS; Dwarakanath BS
Curr Protein Pept Sci; 2018 Feb; 19(4):344-357. PubMed ID: 28079009
[TBL] [Abstract][Full Text] [Related]
4. Biphasic Increases of Cell Surface Calreticulin Following Treatment with Mitoxantrone.
Azuma Y; Suzuki K; Higai K; Matsumoto K; Tada S
Biol Pharm Bull; 2020 Oct; 43(10):1595-1599. PubMed ID: 32727970
[TBL] [Abstract][Full Text] [Related]
5. Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell-driven rejection of high-grade glioma.
Garg AD; Vandenberk L; Koks C; Verschuere T; Boon L; Van Gool SW; Agostinis P
Sci Transl Med; 2016 Mar; 8(328):328ra27. PubMed ID: 26936504
[TBL] [Abstract][Full Text] [Related]
6. Gold Standard Assessment of Immunogenic Cell Death in Oncological Mouse Models.
Humeau J; Lévesque S; Kroemer G; Pol JG
Methods Mol Biol; 2019; 1884():297-315. PubMed ID: 30465212
[TBL] [Abstract][Full Text] [Related]
7. Nano-Pulse Stimulation is a physical modality that can trigger immunogenic tumor cell death.
Nuccitelli R; McDaniel A; Anand S; Cha J; Mallon Z; Berridge JC; Uecker D
J Immunother Cancer; 2017; 5():32. PubMed ID: 28428881
[TBL] [Abstract][Full Text] [Related]
8. Ecto-calreticulin in immunogenic chemotherapy.
Obeid M; Tesniere A; Panaretakis T; Tufi R; Joza N; van Endert P; Ghiringhelli F; Apetoh L; Chaput N; Flament C; Ullrich E; de Botton S; Zitvogel L; Kroemer G
Immunol Rev; 2007 Dec; 220():22-34. PubMed ID: 17979837
[TBL] [Abstract][Full Text] [Related]
9. Calreticulin-Multifunctional Chaperone in Immunogenic Cell Death: Potential Significance as a Prognostic Biomarker in Ovarian Cancer Patients.
Kielbik M; Szulc-Kielbik I; Klink M
Cells; 2021 Jan; 10(1):. PubMed ID: 33440842
[TBL] [Abstract][Full Text] [Related]
10. Quantitative image analysis of intracellular protein translocation in 3-dimensional tissues for pharmacodynamic studies of immunogenic cell death.
Sun Y; Lu Z; Taylor JA; Au JLS
J Control Release; 2024 Jan; 365():89-100. PubMed ID: 37981052
[TBL] [Abstract][Full Text] [Related]
11. Distinct roles in phagocytosis of the early and late increases of cell surface calreticulin induced by oxaliplatin.
Matsusaka K; Azuma Y; Kaga Y; Uchida S; Takebayashi Y; Tsuyama T; Tada S
Biochem Biophys Rep; 2022 Mar; 29():101222. PubMed ID: 35146135
[TBL] [Abstract][Full Text] [Related]
12. Combining cisplatin with Pinellia pedatisecta Schott lipid-soluble extract induces tumor immunogenic cell death in cervical cancer.
Wang C; Zhang M; Peng J; Zhang M; Lu C; Qi X; Luo Q; Wang Y; Li G
Phytomedicine; 2024 Jun; 128():155504. PubMed ID: 38452404
[TBL] [Abstract][Full Text] [Related]
13. Engineering Calreticulin-Targeting Monobodies to Detect Immunogenic Cell Death in Cancer Chemotherapy.
Zhang Y; Thangam R; You SH; Sultonova RD; Venu A; Min JJ; Hong Y
Cancers (Basel); 2021 Jun; 13(11):. PubMed ID: 34199835
[TBL] [Abstract][Full Text] [Related]
14. Clinically Relevant Chemotherapeutics Have the Ability to Induce Immunogenic Cell Death in Non-Small Cell Lung Cancer.
Flieswasser T; Van Loenhout J; Freire Boullosa L; Van den Eynde A; De Waele J; Van Audenaerde J; Lardon F; Smits E; Pauwels P; Jacobs J
Cells; 2020 Jun; 9(6):. PubMed ID: 32560232
[TBL] [Abstract][Full Text] [Related]
15. The co-translocation of ERp57 and calreticulin determines the immunogenicity of cell death.
Panaretakis T; Joza N; Modjtahedi N; Tesniere A; Vitale I; Durchschlag M; Fimia GM; Kepp O; Piacentini M; Froehlich KU; van Endert P; Zitvogel L; Madeo F; Kroemer G
Cell Death Differ; 2008 Sep; 15(9):1499-509. PubMed ID: 18464797
[TBL] [Abstract][Full Text] [Related]
16. An "eat me" combinatory nano-formulation for systemic immunotherapy of solid tumors.
Abdel-Bar HM; Walters AA; Lim Y; Rouatbi N; Qin Y; Gheidari F; Han S; Osman R; Wang JT; Al-Jamal KT
Theranostics; 2021; 11(18):8738-8754. PubMed ID: 34522209
[No Abstract] [Full Text] [Related]
17. Immunogenic calreticulin exposure occurs through a phylogenetically conserved stress pathway involving the chemokine CXCL8.
Sukkurwala AQ; Martins I; Wang Y; Schlemmer F; Ruckenstuhl C; Durchschlag M; Michaud M; Senovilla L; Sistigu A; Ma Y; Vacchelli E; Sulpice E; Gidrol X; Zitvogel L; Madeo F; Galluzzi L; Kepp O; Kroemer G
Cell Death Differ; 2014 Jan; 21(1):59-68. PubMed ID: 23787997
[TBL] [Abstract][Full Text] [Related]
18. Molecular effectors and modulators of hypericin-mediated cell death in bladder cancer cells.
Buytaert E; Matroule JY; Durinck S; Close P; Kocanova S; Vandenheede JR; de Witte PA; Piette J; Agostinis P
Oncogene; 2008 Mar; 27(13):1916-29. PubMed ID: 17952126
[TBL] [Abstract][Full Text] [Related]
19. Sequential Interferon β-Cisplatin Treatment Enhances the Surface Exposure of Calreticulin in Cancer Cells via an Interferon Regulatory Factor 1-Dependent Manner.
Yang PM; Hsieh YY; Du JL; Yen SC; Hung CF
Biomolecules; 2020 Apr; 10(4):. PubMed ID: 32326356
[TBL] [Abstract][Full Text] [Related]
20. Immunogenic Apoptosis as a Novel Tool for Anticancer Vaccine Development.
Montico B; Nigro A; Casolaro V; Dal Col J
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29462947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
